Global Tasigna Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Tasigna market size was valued at US$ 1881.2 million in 2023. With growing demand in downstream market, the Tasigna is forecast to a readjusted size of US$ 1261.4 million by 2030 with a CAGR of -5.5% during review period.
The research report highlights the growth potential of the global Tasigna market. Tasigna are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Tasigna. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Tasigna market.
TASIGNA can be prescribed to treat Philadelphia chromosome-positive chronic myeloid leukemia.
Tasigna, a targeted therapy used in the treatment of certain types of leukemia, is witnessing increasing demand. Factors driving market growth include the rising incidence of leukemia, advancements in precision medicine, and the efficacy of Tasigna in treating resistant forms of the disease. Key players in the market are investing in research and development to expand the indications of Tasigna and explore its potential in combination therapies. Additionally, strategic collaborations and regulatory approvals are contributing to market expansion. However, challenges such as high treatment costs and the availability of generic alternatives may impact market growth.
Key Features:
The report on Tasigna market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Tasigna market. It may include historical data, market segmentation by Type (e.g., 50mg, 200mg), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Tasigna market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Tasigna market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Tasigna industry. This include advancements in Tasigna technology, Tasigna new entrants, Tasigna new investment, and other innovations that are shaping the future of Tasigna.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Tasigna market. It includes factors influencing customer ' purchasing decisions, preferences for Tasigna product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Tasigna market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Tasigna market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Tasigna market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Tasigna industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Tasigna market.
Market Segmentation:
Tasigna market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Tasigna market?
What factors are driving Tasigna market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Tasigna market opportunities vary by end market size?
How does Tasigna break out type, application?
According to our LPI (LP Information) latest study, the global Tasigna market size was valued at US$ 1881.2 million in 2023. With growing demand in downstream market, the Tasigna is forecast to a readjusted size of US$ 1261.4 million by 2030 with a CAGR of -5.5% during review period.
The research report highlights the growth potential of the global Tasigna market. Tasigna are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Tasigna. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Tasigna market.
TASIGNA can be prescribed to treat Philadelphia chromosome-positive chronic myeloid leukemia.
Tasigna, a targeted therapy used in the treatment of certain types of leukemia, is witnessing increasing demand. Factors driving market growth include the rising incidence of leukemia, advancements in precision medicine, and the efficacy of Tasigna in treating resistant forms of the disease. Key players in the market are investing in research and development to expand the indications of Tasigna and explore its potential in combination therapies. Additionally, strategic collaborations and regulatory approvals are contributing to market expansion. However, challenges such as high treatment costs and the availability of generic alternatives may impact market growth.
Key Features:
The report on Tasigna market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Tasigna market. It may include historical data, market segmentation by Type (e.g., 50mg, 200mg), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Tasigna market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Tasigna market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Tasigna industry. This include advancements in Tasigna technology, Tasigna new entrants, Tasigna new investment, and other innovations that are shaping the future of Tasigna.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Tasigna market. It includes factors influencing customer ' purchasing decisions, preferences for Tasigna product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Tasigna market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Tasigna market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Tasigna market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Tasigna industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Tasigna market.
Market Segmentation:
Tasigna market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- 50mg
- 200mg
- Other
- Hospital
- Drugs Store
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novartis
What is the 10-year outlook for the global Tasigna market?
What factors are driving Tasigna market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Tasigna market opportunities vary by end market size?
How does Tasigna break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Tasigna Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Tasigna by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Tasigna by Country/Region, 2019, 2023 & 2030
2.2 Tasigna Segment by Type
2.2.1 50mg
2.2.2 200mg
2.2.3 Other
2.3 Tasigna Sales by Type
2.3.1 Global Tasigna Sales Market Share by Type (2019-2024)
2.3.2 Global Tasigna Revenue and Market Share by Type (2019-2024)
2.3.3 Global Tasigna Sale Price by Type (2019-2024)
2.4 Tasigna Segment by Application
2.4.1 Hospital
2.4.2 Drugs Store
2.4.3 Other
2.5 Tasigna Sales by Application
2.5.1 Global Tasigna Sale Market Share by Application (2019-2024)
2.5.2 Global Tasigna Revenue and Market Share by Application (2019-2024)
2.5.3 Global Tasigna Sale Price by Application (2019-2024)
3 GLOBAL TASIGNA BY COMPANY
3.1 Global Tasigna Breakdown Data by Company
3.1.1 Global Tasigna Annual Sales by Company (2019-2024)
3.1.2 Global Tasigna Sales Market Share by Company (2019-2024)
3.2 Global Tasigna Annual Revenue by Company (2019-2024)
3.2.1 Global Tasigna Revenue by Company (2019-2024)
3.2.2 Global Tasigna Revenue Market Share by Company (2019-2024)
3.3 Global Tasigna Sale Price by Company
3.4 Key Manufacturers Tasigna Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Tasigna Product Location Distribution
3.4.2 Players Tasigna Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR TASIGNA BY GEOGRAPHIC REGION
4.1 World Historic Tasigna Market Size by Geographic Region (2019-2024)
4.1.1 Global Tasigna Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Tasigna Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Tasigna Market Size by Country/Region (2019-2024)
4.2.1 Global Tasigna Annual Sales by Country/Region (2019-2024)
4.2.2 Global Tasigna Annual Revenue by Country/Region (2019-2024)
4.3 Americas Tasigna Sales Growth
4.4 APAC Tasigna Sales Growth
4.5 Europe Tasigna Sales Growth
4.6 Middle East & Africa Tasigna Sales Growth
5 AMERICAS
5.1 Americas Tasigna Sales by Country
5.1.1 Americas Tasigna Sales by Country (2019-2024)
5.1.2 Americas Tasigna Revenue by Country (2019-2024)
5.2 Americas Tasigna Sales by Type
5.3 Americas Tasigna Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tasigna Sales by Region
6.1.1 APAC Tasigna Sales by Region (2019-2024)
6.1.2 APAC Tasigna Revenue by Region (2019-2024)
6.2 APAC Tasigna Sales by Type
6.3 APAC Tasigna Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Tasigna by Country
7.1.1 Europe Tasigna Sales by Country (2019-2024)
7.1.2 Europe Tasigna Revenue by Country (2019-2024)
7.2 Europe Tasigna Sales by Type
7.3 Europe Tasigna Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Tasigna by Country
8.1.1 Middle East & Africa Tasigna Sales by Country (2019-2024)
8.1.2 Middle East & Africa Tasigna Revenue by Country (2019-2024)
8.2 Middle East & Africa Tasigna Sales by Type
8.3 Middle East & Africa Tasigna Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Tasigna
10.3 Manufacturing Process Analysis of Tasigna
10.4 Industry Chain Structure of Tasigna
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Tasigna Distributors
11.3 Tasigna Customer
12 WORLD FORECAST REVIEW FOR TASIGNA BY GEOGRAPHIC REGION
12.1 Global Tasigna Market Size Forecast by Region
12.1.1 Global Tasigna Forecast by Region (2025-2030)
12.1.2 Global Tasigna Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Tasigna Forecast by Type
12.7 Global Tasigna Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Tasigna Product Portfolios and Specifications
13.1.3 Novartis Tasigna Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Tasigna Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Tasigna by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Tasigna by Country/Region, 2019, 2023 & 2030
2.2 Tasigna Segment by Type
2.2.1 50mg
2.2.2 200mg
2.2.3 Other
2.3 Tasigna Sales by Type
2.3.1 Global Tasigna Sales Market Share by Type (2019-2024)
2.3.2 Global Tasigna Revenue and Market Share by Type (2019-2024)
2.3.3 Global Tasigna Sale Price by Type (2019-2024)
2.4 Tasigna Segment by Application
2.4.1 Hospital
2.4.2 Drugs Store
2.4.3 Other
2.5 Tasigna Sales by Application
2.5.1 Global Tasigna Sale Market Share by Application (2019-2024)
2.5.2 Global Tasigna Revenue and Market Share by Application (2019-2024)
2.5.3 Global Tasigna Sale Price by Application (2019-2024)
3 GLOBAL TASIGNA BY COMPANY
3.1 Global Tasigna Breakdown Data by Company
3.1.1 Global Tasigna Annual Sales by Company (2019-2024)
3.1.2 Global Tasigna Sales Market Share by Company (2019-2024)
3.2 Global Tasigna Annual Revenue by Company (2019-2024)
3.2.1 Global Tasigna Revenue by Company (2019-2024)
3.2.2 Global Tasigna Revenue Market Share by Company (2019-2024)
3.3 Global Tasigna Sale Price by Company
3.4 Key Manufacturers Tasigna Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Tasigna Product Location Distribution
3.4.2 Players Tasigna Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR TASIGNA BY GEOGRAPHIC REGION
4.1 World Historic Tasigna Market Size by Geographic Region (2019-2024)
4.1.1 Global Tasigna Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Tasigna Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Tasigna Market Size by Country/Region (2019-2024)
4.2.1 Global Tasigna Annual Sales by Country/Region (2019-2024)
4.2.2 Global Tasigna Annual Revenue by Country/Region (2019-2024)
4.3 Americas Tasigna Sales Growth
4.4 APAC Tasigna Sales Growth
4.5 Europe Tasigna Sales Growth
4.6 Middle East & Africa Tasigna Sales Growth
5 AMERICAS
5.1 Americas Tasigna Sales by Country
5.1.1 Americas Tasigna Sales by Country (2019-2024)
5.1.2 Americas Tasigna Revenue by Country (2019-2024)
5.2 Americas Tasigna Sales by Type
5.3 Americas Tasigna Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tasigna Sales by Region
6.1.1 APAC Tasigna Sales by Region (2019-2024)
6.1.2 APAC Tasigna Revenue by Region (2019-2024)
6.2 APAC Tasigna Sales by Type
6.3 APAC Tasigna Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Tasigna by Country
7.1.1 Europe Tasigna Sales by Country (2019-2024)
7.1.2 Europe Tasigna Revenue by Country (2019-2024)
7.2 Europe Tasigna Sales by Type
7.3 Europe Tasigna Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Tasigna by Country
8.1.1 Middle East & Africa Tasigna Sales by Country (2019-2024)
8.1.2 Middle East & Africa Tasigna Revenue by Country (2019-2024)
8.2 Middle East & Africa Tasigna Sales by Type
8.3 Middle East & Africa Tasigna Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Tasigna
10.3 Manufacturing Process Analysis of Tasigna
10.4 Industry Chain Structure of Tasigna
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Tasigna Distributors
11.3 Tasigna Customer
12 WORLD FORECAST REVIEW FOR TASIGNA BY GEOGRAPHIC REGION
12.1 Global Tasigna Market Size Forecast by Region
12.1.1 Global Tasigna Forecast by Region (2025-2030)
12.1.2 Global Tasigna Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Tasigna Forecast by Type
12.7 Global Tasigna Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Tasigna Product Portfolios and Specifications
13.1.3 Novartis Tasigna Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Tasigna Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Tasigna Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of 50mg
Table 4. Major Players of 200mg
Table 5. Major Players of Other
Table 6. Global Tasigna Sales by Type (2019-2024) & (K Units)
Table 7. Global Tasigna Sales Market Share by Type (2019-2024)
Table 8. Global Tasigna Revenue by Type (2019-2024) & ($ million)
Table 9. Global Tasigna Revenue Market Share by Type (2019-2024)
Table 10. Global Tasigna Sale Price by Type (2019-2024) & (USD/Unit)
Table 11. Global Tasigna Sales by Application (2019-2024) & (K Units)
Table 12. Global Tasigna Sales Market Share by Application (2019-2024)
Table 13. Global Tasigna Revenue by Application (2019-2024)
Table 14. Global Tasigna Revenue Market Share by Application (2019-2024)
Table 15. Global Tasigna Sale Price by Application (2019-2024) & (USD/Unit)
Table 16. Global Tasigna Sales by Company (2019-2024) & (K Units)
Table 17. Global Tasigna Sales Market Share by Company (2019-2024)
Table 18. Global Tasigna Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Tasigna Revenue Market Share by Company (2019-2024)
Table 20. Global Tasigna Sale Price by Company (2019-2024) & (USD/Unit)
Table 21. Key Manufacturers Tasigna Producing Area Distribution and Sales Area
Table 22. Players Tasigna Products Offered
Table 23. Tasigna Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Tasigna Sales by Geographic Region (2019-2024) & (K Units)
Table 27. Global Tasigna Sales Market Share Geographic Region (2019-2024)
Table 28. Global Tasigna Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Tasigna Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Tasigna Sales by Country/Region (2019-2024) & (K Units)
Table 31. Global Tasigna Sales Market Share by Country/Region (2019-2024)
Table 32. Global Tasigna Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Tasigna Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Tasigna Sales by Country (2019-2024) & (K Units)
Table 35. Americas Tasigna Sales Market Share by Country (2019-2024)
Table 36. Americas Tasigna Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Tasigna Revenue Market Share by Country (2019-2024)
Table 38. Americas Tasigna Sales by Type (2019-2024) & (K Units)
Table 39. Americas Tasigna Sales by Application (2019-2024) & (K Units)
Table 40. APAC Tasigna Sales by Region (2019-2024) & (K Units)
Table 41. APAC Tasigna Sales Market Share by Region (2019-2024)
Table 42. APAC Tasigna Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Tasigna Revenue Market Share by Region (2019-2024)
Table 44. APAC Tasigna Sales by Type (2019-2024) & (K Units)
Table 45. APAC Tasigna Sales by Application (2019-2024) & (K Units)
Table 46. Europe Tasigna Sales by Country (2019-2024) & (K Units)
Table 47. Europe Tasigna Sales Market Share by Country (2019-2024)
Table 48. Europe Tasigna Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Tasigna Revenue Market Share by Country (2019-2024)
Table 50. Europe Tasigna Sales by Type (2019-2024) & (K Units)
Table 51. Europe Tasigna Sales by Application (2019-2024) & (K Units)
Table 52. Middle East & Africa Tasigna Sales by Country (2019-2024) & (K Units)
Table 53. Middle East & Africa Tasigna Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Tasigna Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Tasigna Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Tasigna Sales by Type (2019-2024) & (K Units)
Table 57. Middle East & Africa Tasigna Sales by Application (2019-2024) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Tasigna
Table 59. Key Market Challenges & Risks of Tasigna
Table 60. Key Industry Trends of Tasigna
Table 61. Tasigna Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Tasigna Distributors List
Table 64. Tasigna Customer List
Table 65. Global Tasigna Sales Forecast by Region (2025-2030) & (K Units)
Table 66. Global Tasigna Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Tasigna Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Americas Tasigna Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Tasigna Sales Forecast by Region (2025-2030) & (K Units)
Table 70. APAC Tasigna Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Tasigna Sales Forecast by Country (2025-2030) & (K Units)
Table 72. Europe Tasigna Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Tasigna Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Middle East & Africa Tasigna Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Tasigna Sales Forecast by Type (2025-2030) & (K Units)
Table 76. Global Tasigna Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global Tasigna Sales Forecast by Application (2025-2030) & (K Units)
Table 78. Global Tasigna Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. Novartis Basic Information, Tasigna Manufacturing Base, Sales Area and Its Competitors
Table 80. Novartis Tasigna Product Portfolios and Specifications
Table 81. Novartis Tasigna Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. Novartis Main Business
Table 83. Novartis Latest Developments
Table 1. Tasigna Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Tasigna Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of 50mg
Table 4. Major Players of 200mg
Table 5. Major Players of Other
Table 6. Global Tasigna Sales by Type (2019-2024) & (K Units)
Table 7. Global Tasigna Sales Market Share by Type (2019-2024)
Table 8. Global Tasigna Revenue by Type (2019-2024) & ($ million)
Table 9. Global Tasigna Revenue Market Share by Type (2019-2024)
Table 10. Global Tasigna Sale Price by Type (2019-2024) & (USD/Unit)
Table 11. Global Tasigna Sales by Application (2019-2024) & (K Units)
Table 12. Global Tasigna Sales Market Share by Application (2019-2024)
Table 13. Global Tasigna Revenue by Application (2019-2024)
Table 14. Global Tasigna Revenue Market Share by Application (2019-2024)
Table 15. Global Tasigna Sale Price by Application (2019-2024) & (USD/Unit)
Table 16. Global Tasigna Sales by Company (2019-2024) & (K Units)
Table 17. Global Tasigna Sales Market Share by Company (2019-2024)
Table 18. Global Tasigna Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Tasigna Revenue Market Share by Company (2019-2024)
Table 20. Global Tasigna Sale Price by Company (2019-2024) & (USD/Unit)
Table 21. Key Manufacturers Tasigna Producing Area Distribution and Sales Area
Table 22. Players Tasigna Products Offered
Table 23. Tasigna Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Tasigna Sales by Geographic Region (2019-2024) & (K Units)
Table 27. Global Tasigna Sales Market Share Geographic Region (2019-2024)
Table 28. Global Tasigna Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Tasigna Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Tasigna Sales by Country/Region (2019-2024) & (K Units)
Table 31. Global Tasigna Sales Market Share by Country/Region (2019-2024)
Table 32. Global Tasigna Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Tasigna Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Tasigna Sales by Country (2019-2024) & (K Units)
Table 35. Americas Tasigna Sales Market Share by Country (2019-2024)
Table 36. Americas Tasigna Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Tasigna Revenue Market Share by Country (2019-2024)
Table 38. Americas Tasigna Sales by Type (2019-2024) & (K Units)
Table 39. Americas Tasigna Sales by Application (2019-2024) & (K Units)
Table 40. APAC Tasigna Sales by Region (2019-2024) & (K Units)
Table 41. APAC Tasigna Sales Market Share by Region (2019-2024)
Table 42. APAC Tasigna Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Tasigna Revenue Market Share by Region (2019-2024)
Table 44. APAC Tasigna Sales by Type (2019-2024) & (K Units)
Table 45. APAC Tasigna Sales by Application (2019-2024) & (K Units)
Table 46. Europe Tasigna Sales by Country (2019-2024) & (K Units)
Table 47. Europe Tasigna Sales Market Share by Country (2019-2024)
Table 48. Europe Tasigna Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Tasigna Revenue Market Share by Country (2019-2024)
Table 50. Europe Tasigna Sales by Type (2019-2024) & (K Units)
Table 51. Europe Tasigna Sales by Application (2019-2024) & (K Units)
Table 52. Middle East & Africa Tasigna Sales by Country (2019-2024) & (K Units)
Table 53. Middle East & Africa Tasigna Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Tasigna Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Tasigna Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Tasigna Sales by Type (2019-2024) & (K Units)
Table 57. Middle East & Africa Tasigna Sales by Application (2019-2024) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Tasigna
Table 59. Key Market Challenges & Risks of Tasigna
Table 60. Key Industry Trends of Tasigna
Table 61. Tasigna Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Tasigna Distributors List
Table 64. Tasigna Customer List
Table 65. Global Tasigna Sales Forecast by Region (2025-2030) & (K Units)
Table 66. Global Tasigna Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Tasigna Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Americas Tasigna Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Tasigna Sales Forecast by Region (2025-2030) & (K Units)
Table 70. APAC Tasigna Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Tasigna Sales Forecast by Country (2025-2030) & (K Units)
Table 72. Europe Tasigna Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Tasigna Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Middle East & Africa Tasigna Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Tasigna Sales Forecast by Type (2025-2030) & (K Units)
Table 76. Global Tasigna Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global Tasigna Sales Forecast by Application (2025-2030) & (K Units)
Table 78. Global Tasigna Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. Novartis Basic Information, Tasigna Manufacturing Base, Sales Area and Its Competitors
Table 80. Novartis Tasigna Product Portfolios and Specifications
Table 81. Novartis Tasigna Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. Novartis Main Business
Table 83. Novartis Latest Developments
LIST OF FIGURES
Figure 1. Picture of Tasigna
Figure 2. Tasigna Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Tasigna Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Tasigna Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Tasigna Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of 50mg
Figure 10. Product Picture of 200mg
Figure 11. Product Picture of Other
Figure 12. Global Tasigna Sales Market Share by Type in 2023
Figure 13. Global Tasigna Revenue Market Share by Type (2019-2024)
Figure 14. Tasigna Consumed in Hospital
Figure 15. Global Tasigna Market: Hospital (2019-2024) & (K Units)
Figure 16. Tasigna Consumed in Drugs Store
Figure 17. Global Tasigna Market: Drugs Store (2019-2024) & (K Units)
Figure 18. Tasigna Consumed in Other
Figure 19. Global Tasigna Market: Other (2019-2024) & (K Units)
Figure 20. Global Tasigna Sales Market Share by Application (2023)
Figure 21. Global Tasigna Revenue Market Share by Application in 2023
Figure 22. Tasigna Sales Market by Company in 2023 (K Units)
Figure 23. Global Tasigna Sales Market Share by Company in 2023
Figure 24. Tasigna Revenue Market by Company in 2023 ($ Million)
Figure 25. Global Tasigna Revenue Market Share by Company in 2023
Figure 26. Global Tasigna Sales Market Share by Geographic Region (2019-2024)
Figure 27. Global Tasigna Revenue Market Share by Geographic Region in 2023
Figure 28. Americas Tasigna Sales 2019-2024 (K Units)
Figure 29. Americas Tasigna Revenue 2019-2024 ($ Millions)
Figure 30. APAC Tasigna Sales 2019-2024 (K Units)
Figure 31. APAC Tasigna Revenue 2019-2024 ($ Millions)
Figure 32. Europe Tasigna Sales 2019-2024 (K Units)
Figure 33. Europe Tasigna Revenue 2019-2024 ($ Millions)
Figure 34. Middle East & Africa Tasigna Sales 2019-2024 (K Units)
Figure 35. Middle East & Africa Tasigna Revenue 2019-2024 ($ Millions)
Figure 36. Americas Tasigna Sales Market Share by Country in 2023
Figure 37. Americas Tasigna Revenue Market Share by Country in 2023
Figure 38. Americas Tasigna Sales Market Share by Type (2019-2024)
Figure 39. Americas Tasigna Sales Market Share by Application (2019-2024)
Figure 40. United States Tasigna Revenue Growth 2019-2024 ($ Millions)
Figure 41. Canada Tasigna Revenue Growth 2019-2024 ($ Millions)
Figure 42. Mexico Tasigna Revenue Growth 2019-2024 ($ Millions)
Figure 43. Brazil Tasigna Revenue Growth 2019-2024 ($ Millions)
Figure 44. APAC Tasigna Sales Market Share by Region in 2023
Figure 45. APAC Tasigna Revenue Market Share by Regions in 2023
Figure 46. APAC Tasigna Sales Market Share by Type (2019-2024)
Figure 47. APAC Tasigna Sales Market Share by Application (2019-2024)
Figure 48. China Tasigna Revenue Growth 2019-2024 ($ Millions)
Figure 49. Japan Tasigna Revenue Growth 2019-2024 ($ Millions)
Figure 50. South Korea Tasigna Revenue Growth 2019-2024 ($ Millions)
Figure 51. Southeast Asia Tasigna Revenue Growth 2019-2024 ($ Millions)
Figure 52. India Tasigna Revenue Growth 2019-2024 ($ Millions)
Figure 53. Australia Tasigna Revenue Growth 2019-2024 ($ Millions)
Figure 54. China Taiwan Tasigna Revenue Growth 2019-2024 ($ Millions)
Figure 55. Europe Tasigna Sales Market Share by Country in 2023
Figure 56. Europe Tasigna Revenue Market Share by Country in 2023
Figure 57. Europe Tasigna Sales Market Share by Type (2019-2024)
Figure 58. Europe Tasigna Sales Market Share by Application (2019-2024)
Figure 59. Germany Tasigna Revenue Growth 2019-2024 ($ Millions)
Figure 60. France Tasigna Revenue Growth 2019-2024 ($ Millions)
Figure 61. UK Tasigna Revenue Growth 2019-2024 ($ Millions)
Figure 62. Italy Tasigna Revenue Growth 2019-2024 ($ Millions)
Figure 63. Russia Tasigna Revenue Growth 2019-2024 ($ Millions)
Figure 64. Middle East & Africa Tasigna Sales Market Share by Country in 2023
Figure 65. Middle East & Africa Tasigna Revenue Market Share by Country in 2023
Figure 66. Middle East & Africa Tasigna Sales Market Share by Type (2019-2024)
Figure 67. Middle East & Africa Tasigna Sales Market Share by Application (2019-2024)
Figure 68. Egypt Tasigna Revenue Growth 2019-2024 ($ Millions)
Figure 69. South Africa Tasigna Revenue Growth 2019-2024 ($ Millions)
Figure 70. Israel Tasigna Revenue Growth 2019-2024 ($ Millions)
Figure 71. Turkey Tasigna Revenue Growth 2019-2024 ($ Millions)
Figure 72. GCC Country Tasigna Revenue Growth 2019-2024 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Tasigna in 2023
Figure 74. Manufacturing Process Analysis of Tasigna
Figure 75. Industry Chain Structure of Tasigna
Figure 76. Channels of Distribution
Figure 77. Global Tasigna Sales Market Forecast by Region (2025-2030)
Figure 78. Global Tasigna Revenue Market Share Forecast by Region (2025-2030)
Figure 79. Global Tasigna Sales Market Share Forecast by Type (2025-2030)
Figure 80. Global Tasigna Revenue Market Share Forecast by Type (2025-2030)
Figure 81. Global Tasigna Sales Market Share Forecast by Application (2025-2030)
Figure 82. Global Tasigna Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Tasigna
Figure 2. Tasigna Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Tasigna Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Tasigna Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Tasigna Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of 50mg
Figure 10. Product Picture of 200mg
Figure 11. Product Picture of Other
Figure 12. Global Tasigna Sales Market Share by Type in 2023
Figure 13. Global Tasigna Revenue Market Share by Type (2019-2024)
Figure 14. Tasigna Consumed in Hospital
Figure 15. Global Tasigna Market: Hospital (2019-2024) & (K Units)
Figure 16. Tasigna Consumed in Drugs Store
Figure 17. Global Tasigna Market: Drugs Store (2019-2024) & (K Units)
Figure 18. Tasigna Consumed in Other
Figure 19. Global Tasigna Market: Other (2019-2024) & (K Units)
Figure 20. Global Tasigna Sales Market Share by Application (2023)
Figure 21. Global Tasigna Revenue Market Share by Application in 2023
Figure 22. Tasigna Sales Market by Company in 2023 (K Units)
Figure 23. Global Tasigna Sales Market Share by Company in 2023
Figure 24. Tasigna Revenue Market by Company in 2023 ($ Million)
Figure 25. Global Tasigna Revenue Market Share by Company in 2023
Figure 26. Global Tasigna Sales Market Share by Geographic Region (2019-2024)
Figure 27. Global Tasigna Revenue Market Share by Geographic Region in 2023
Figure 28. Americas Tasigna Sales 2019-2024 (K Units)
Figure 29. Americas Tasigna Revenue 2019-2024 ($ Millions)
Figure 30. APAC Tasigna Sales 2019-2024 (K Units)
Figure 31. APAC Tasigna Revenue 2019-2024 ($ Millions)
Figure 32. Europe Tasigna Sales 2019-2024 (K Units)
Figure 33. Europe Tasigna Revenue 2019-2024 ($ Millions)
Figure 34. Middle East & Africa Tasigna Sales 2019-2024 (K Units)
Figure 35. Middle East & Africa Tasigna Revenue 2019-2024 ($ Millions)
Figure 36. Americas Tasigna Sales Market Share by Country in 2023
Figure 37. Americas Tasigna Revenue Market Share by Country in 2023
Figure 38. Americas Tasigna Sales Market Share by Type (2019-2024)
Figure 39. Americas Tasigna Sales Market Share by Application (2019-2024)
Figure 40. United States Tasigna Revenue Growth 2019-2024 ($ Millions)
Figure 41. Canada Tasigna Revenue Growth 2019-2024 ($ Millions)
Figure 42. Mexico Tasigna Revenue Growth 2019-2024 ($ Millions)
Figure 43. Brazil Tasigna Revenue Growth 2019-2024 ($ Millions)
Figure 44. APAC Tasigna Sales Market Share by Region in 2023
Figure 45. APAC Tasigna Revenue Market Share by Regions in 2023
Figure 46. APAC Tasigna Sales Market Share by Type (2019-2024)
Figure 47. APAC Tasigna Sales Market Share by Application (2019-2024)
Figure 48. China Tasigna Revenue Growth 2019-2024 ($ Millions)
Figure 49. Japan Tasigna Revenue Growth 2019-2024 ($ Millions)
Figure 50. South Korea Tasigna Revenue Growth 2019-2024 ($ Millions)
Figure 51. Southeast Asia Tasigna Revenue Growth 2019-2024 ($ Millions)
Figure 52. India Tasigna Revenue Growth 2019-2024 ($ Millions)
Figure 53. Australia Tasigna Revenue Growth 2019-2024 ($ Millions)
Figure 54. China Taiwan Tasigna Revenue Growth 2019-2024 ($ Millions)
Figure 55. Europe Tasigna Sales Market Share by Country in 2023
Figure 56. Europe Tasigna Revenue Market Share by Country in 2023
Figure 57. Europe Tasigna Sales Market Share by Type (2019-2024)
Figure 58. Europe Tasigna Sales Market Share by Application (2019-2024)
Figure 59. Germany Tasigna Revenue Growth 2019-2024 ($ Millions)
Figure 60. France Tasigna Revenue Growth 2019-2024 ($ Millions)
Figure 61. UK Tasigna Revenue Growth 2019-2024 ($ Millions)
Figure 62. Italy Tasigna Revenue Growth 2019-2024 ($ Millions)
Figure 63. Russia Tasigna Revenue Growth 2019-2024 ($ Millions)
Figure 64. Middle East & Africa Tasigna Sales Market Share by Country in 2023
Figure 65. Middle East & Africa Tasigna Revenue Market Share by Country in 2023
Figure 66. Middle East & Africa Tasigna Sales Market Share by Type (2019-2024)
Figure 67. Middle East & Africa Tasigna Sales Market Share by Application (2019-2024)
Figure 68. Egypt Tasigna Revenue Growth 2019-2024 ($ Millions)
Figure 69. South Africa Tasigna Revenue Growth 2019-2024 ($ Millions)
Figure 70. Israel Tasigna Revenue Growth 2019-2024 ($ Millions)
Figure 71. Turkey Tasigna Revenue Growth 2019-2024 ($ Millions)
Figure 72. GCC Country Tasigna Revenue Growth 2019-2024 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Tasigna in 2023
Figure 74. Manufacturing Process Analysis of Tasigna
Figure 75. Industry Chain Structure of Tasigna
Figure 76. Channels of Distribution
Figure 77. Global Tasigna Sales Market Forecast by Region (2025-2030)
Figure 78. Global Tasigna Revenue Market Share Forecast by Region (2025-2030)
Figure 79. Global Tasigna Sales Market Share Forecast by Type (2025-2030)
Figure 80. Global Tasigna Revenue Market Share Forecast by Type (2025-2030)
Figure 81. Global Tasigna Sales Market Share Forecast by Application (2025-2030)
Figure 82. Global Tasigna Revenue Market Share Forecast by Application (2025-2030)
More Publications
Global Portable Electric Stimulator Market Growth 2023-2029
US$ 3,660.00
March 2023
125 pages
Global Trimebutine Market Growth 2024-2030
US$ 3,660.00
March 2024
92 pages
